title: Differential regulation of HIV-1 clade-specific B, C, and E long terminal repeats by NF-kappaB and the Tat transactivator.
abstract: The major group of human immunodeficiency viruses (HIV-1) that comprise the current global pandemic have diversified during their worldwide spread and may be divided into at least 10 distinct subtypes or clades, A through J. Subtype B predominates in North America and Europe, subtype E predominates in Southeast Asia, and subtype C predominates in sub-Saharan Africa. Functional distinctions in long terminal repeat (LTR) architecture among HIV subtypes have been identified, thus raising the possibility that regulatory divergence among the subtypes of HIV-1 has occurred. In addition to the transcriptional specificity of the HIV-1 LTR, productive HIV-1 replication is also dependent upon the viral Tat protein. Therefore, we sought to investigate whether interactions between host signaling pathways and the NF-kappaB regions of different HIV-1 subtypes, together with subtype-specific interactions between Tat, TAR, and cellular proteins, modulate the efficiency of HIV-1 clade-specific gene transcription. We demonstrate that the NF-kappaB sites of subtypes B and E both bind NF-kappaB-related complexes. However, the duplicated kappaB sites of the C subtype do not compete for NF-kappaB binding. Also, clade E Tat protein possesses the highest transactivation capacity, regardless of the LTR context. Furthermore, preliminary evidence suggests that the acetylation of subtype-specific Tat proteins may correlate with their transactivation efficiency.
authors.affiliation: McGill AIDS Center, McGill University, Montréal, Québec, Canada.
authors.forename: Philippe
authors.initials: P
authors.lastname: Roof
authors.forename: Maria
authors.initials: M
authors.lastname: Ricci
authors.forename: Pierre
authors.initials: P
authors.lastname: Genin
authors.forename: Monty A
authors.initials: MA
authors.lastname: Montano
authors.forename: Max
authors.initials: M
authors.lastname: Essex
authors.forename: Mark A
authors.initials: MA
authors.lastname: Wainberg
authors.forename: Anne
authors.initials: A
authors.lastname: Gatignol
authors.forename: John
authors.initials: J
authors.lastname: Hiscott
mesh_terms: D000595:Amino Acid Sequence; D015967:Gene Expression Regulation, Viral; D015696:Gene Products, tat / Q000235:genetics*; D016322:HIV Enhancer / Q000235:genetics; D016325:HIV Long Terminal Repeat / Q000235:genetics*; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D019169:Jurkat Cells; D008969:Molecular Sequence Data; D016328:NF-kappa B / Q000235:genetics; D016415:Sequence Alignment; D014158:Transcription, Genetic; D020298:U937 Cells; D054322:tat Gene Products, Human Immunodeficiency Virus
chemical_list: D015696:Gene Products, tat; D016328:NF-kappa B; D054322:tat Gene Products, Human Immunodeficiency Virus